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Abstract
Background: Palliative care (PC) is an approach that improves the quality of life (QoL) of patients and their families
facing the problem associated with incurable terminal disease. A number of QoL assessment tools have been validated
in PC and their use described for research purposes, to support clinical practice, and as part of the quality improvement
programs. There is a paucity of evidence on the implementation of a nursing intervention focused on QoL assessment
in PC practice.
The aim of this study is to model and determine the feasibility of a nursing complex intervention focused on QoL
assessment in PC practice.
Methods: The intervention will be evaluated through a quasi-experimental non-equivalent comparison group
before-after study design. This project can be classified as phases 1–2, according to the Medical Research Council
(MRC) framework for the development and evaluation of complex interventions.
The study setting will take place in two inpatient hospice units in Italy. The study sample will be constituted of 39
multidisciplinary healthcare professionals and a sample of 46 advanced cancer patients admitted to hospices during the
implementation of the intervention.
Discussion: This study will generate information to address the implementation of QoL measurement in palliative care
practice. Findings of this study will be used to inform a phase 3 trial according to the MRC framework.
Trial registration: ISRCTN41201864 retrospectively registered.
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Background
Although quality of life (QoL) assessment is a central
concept in palliative care (PC) practice [1], the standardized
application of clinical interventions focused on assessing
QoL in clinical practice is limited. In addition, current
research is insufficient to determine how to implement such
interventions and determine their impact on patient
outcomes [2, 3].
QoL has been described as the gap between individual’s
expectations and their perception of a given situation [4],
and its management entails the use of a QoL tool to
screen and then monitor QoL changes over time.
Recently, authors of a systematic review on facilitators and
barriers to the successful implementation of Patient-
Reported Outcome Measures (PROMs) in PC recom-
mended tailoring this implementation according to the
setting, having a coordinator throughout the implementa-
tion process, offering all staff an educational program, and
recognizing the ongoing cognitive and emotional
processes in each individual [5].
During the previous decade, a number of QoL meas-
urement intervention components targeted at staff and
practice in PC have been suggested such as choosing a
tool, identifying a leader of the project, and staff training
[6]. In addition, a European-funded research project—the
PRISMA-FP7 project—introduced standards for the meas-
urement of outcomes in PC [7], and more recently, an
evidence-based clinical guidance on how to respond to
patient-reported outcomes measurement in clinical care
was proposed [8]. These initiatives indirectly emphasized
both the inherent complexity of such interventions and the
need for clinicians to respond to the patients’ complex
needs. International scientific associations contribute to a
growing body of guidelines claiming that QoL dimensions
need to be comprehensively assessed and documented
using available standardized scales [9].
In 2010, a systematic review conducted to determine
the availability of PROMs to assess QoL in PC identified
many measurement instruments and concluded that
there was no agreement on how quality of life should be
measured [10]. A subsequent systematic review evalu-
ated to what extent interventions focused on QoL
assessment improve PC patient outcomes revealed that
overall implementation interventions focused on QoL
assessment in PC practice do result in improved patient
outcomes. Although included studies suffered from
small sample size and selection, attrition, and perform-
ance bias, findings showed that such interventions can
have a moderate practical significance on symptoms,
psychosocial dimensions, and overall QoL [2].
Therefore, we designed an evidence-based intervention
focused on QoL measurement in PC practice developed
according to the Medical Research Council (MRC)
framework for developing and evaluating complex
interventions [11]. We are interested in understanding
the feasibility of implementing the intervention in PC
practice to inform the design of a phase 3 randomized
controlled trial.
Aims
The aim of the present study is to model and determine
the feasibility of a nursing complex intervention focused
on QoL assessment in PC practice and developed
according to the MRC framework for developing, imple-
menting, and evaluating complex interventions [11].
Methods/design
Our study is designed to improve PC patients’ QoL (i.e.,
prevent/manage impaired QoL) during admission to an
inpatient hospice unit. Flowchart of the entire interven-
tion focused on QoL measurement (INFO-QoL) project
and this study protocol (phases 1–2) are shown in Fig. 1.
Operational definitions
For the purpose of this study, QoL was defined as the
gap between a person’s life experience and expectations
[4]. Addressing the problem (i.e., impaired QoL) begins
by assessing patient’s QoL, and the information collected
will serve as a basis to formulate realistic goals [7].
Our primary hypothesis is that patients, who will be
cared for by hospice staff that have implemented a
nurse-led complex intervention focused on QoL meas-
urement, will have a significantly better QoL compared
with patients cared for by staff that provide traditional
care.
According to the MRC framework, the primary object-
ive of the study is to model the INFO-QoL intervention
(phase 1) and determine the feasibility, acceptability, and
potential effectiveness of the INFO-QoL intervention
(phase 2).
The secondary objective is to pilot methods for a
phase 3 randomized controlled trial including sample
size, the power of the study, recruitment, follow-up, suit-
ability of measures, and documentations.
The research questions are the following:
1. Are the procedures of the INFO-QoL conveniently
performed as planned to yield information on patients’
needs within a reasonable time frame?
2. Is the INFO-QoL acceptable to hospice staff and
their patients?
3. What is the potential effectiveness of the
implementation of the INFO-QoL in terms of patients’
QoL and QoL-related management actions taken by
PC staff per patient?
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Conceptual model
The study will be based on the conceptual model of The
QoL Assessment Principles in Palliative Care developed
according to phase 0 of the MRC framework. It consists
of four sections, for a total of 11 principles to be considered
in developing and/or evaluating clinical interventions
focused on QoL assessment in PC. The model has been
proposed as a methodological and ethical standard to be
considered when developing and evaluating clinical
interventions focused on QoL assessment in PC.
Section one includes three principles related to “the
problem” (i.e., a QoL impairment), section two
includes two principles dealing with the assessment
tool, section three includes one principle focusing on
the treatment/intervention, and section four includes
five principles dealing with “the clinical intervention
focused on QoL assessment” [12] (Table 1).
Intervention design (theoretical phase)
The development of the INFO-QoL was carried out
through several stages hereafter described (1) We
conceptualized that any intervention focused on QoL
assessment is a complex intervention and as such
includes many components that form a coherent struc-
ture that links the intervention to patient’s QoL [12].
(2) We developed the conceptual model of The QoL
Assessment Principles in Palliative Care by adapting
the WHO Screening Principles framework [13] to QoL
assessment in PC [12]. (3) We identified the compo-
nents and the extent of the outcomes resulting from
the interventions focused on QoL measurement by
systematically reviewing the literature [2, 14]. (4) We
Fig. 1 Flowchart of the INFO-QoL study
Table 1 The Qol assessment principles in palliative care
The problem (the Qol impairment)
1. The problem should be a serious condition for the patient either in
terms of prevalence (e.g., pain, depression) and/or distress for the
patient (e.g., itch, hiccup) or the result of late detection and
management of the problem (e.g., a new or unusual distressing
symptom occurred over the disease trajectory).
2. The problem should be highly unlikely to be reported by the patient
or recognized by the professional if not actively assessed.
3. The trajectory of the problem should be sufficiently understood to
assure a timely assessment to anticipate and appropriately address the
problem.
The assessment tool
4. A validated, reliable, and sensitive-to-change tool for detecting and
measuring the problem should be available.
5. The tool should be practical and easy to use, and questions must not
be distressing for the patients.
The treatment-intervention
6. There should be an appropriate treatment/intervention for patients
with the recognized problem.
The clinical intervention focused on Qol assessment
7. There should be an agreed policy on which a problem (or a problem
with a certain degree of impairment) has to be addressed with
appropriate treatment or intervention.
8. It should be possible for the tool to be appropriately administered by
professionals trained in the procedure.
9. The treatment-intervention for patients with QoL impairments should
be available, with appropriately trained professionals.
10. The cost of problem-finding (including all the steps from the admin
istration of the tool until the treatment-intervention has been delivered
in full) should be economically justified.
11. QoL assessment should be a continuing process rather than a one-
off assessment.
Adapted from Catania et al. [12]
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identified the key elements that led to successful QoL
measurement and then determined whether such
components could be used in Italy by undertaking a
study visit at St. Christopher’s Hospice in UK granted
by the European Oncology Nursing Society (EONS)
through the Clinical Travel Grant 2012. After asking
the experts in the hospice, they emphasized that com-
ponents such as staff education, measurement time-
frame, designated person in charge of the process, and
results discussed during unit staff briefing were the key
elements they addressed before starting up QoL
measurement [15]. Such components need to be locally
adapted before their implementation in Italy. The final
version of the INFO-QoL is described in Table 2.
Study population
The study will be conducted on a convenience sample of
two hospice units of the urban district of Genoa in the
north of Italy: the Gigi Ghirotti Bolzaneto Hospice is a
12-bed nonprofit hospice (Gigi Ghirotti Hospice—Asso-
ciation for Research and Treatment of Pain and Palliative
Care), and the Maria Chighine Hospice is a 12-bed public
hospice (IRCCS AOU San Martino—IST—Teaching
Hospital and Cancer Research Centre). In both of these
hospice units, healthcare professionals were educated and
trained in PC and communication in end-of-life care and
are using the Liverpool Care Pathway [16]. According to
the definition of the European Association for Palliative
Care, “they admit patients in their last phase of life when
treatment in the hospital is not necessary and care at
home or in nursing home is not possible” [17]. The
National Health System covers all or part of the costs of
the care for the public and nonprofit hospice, respectively.
The hospice staff of the Ghirotti Hospice includes 1
physician, 10 nurses, and 6 nursing assistants, and the
Maria Chighine Hospice includes 3 physicians, 12 nurses,
and 7 nursing assistants.
The sample will consist of all the PC team members
within the two hospices during the modeling and
feasibility phase. During the 6-month period of the
feasibility phase (pre-test = 3 months; post-test =
3 months), all adult cancer patients newly admitted to
the hospice units will be invited to participate in the
study and they will be included after giving their
informed consent. Patients too ill to receive the
intervention or unable to give informed consent either
due to cognitive impairment or because they are
unable to understand Italian will be excluded.
The modeling phase
The modeling phase will be conducted through a quali-
tative approach:
Table 2 The intervention focused on quality of life
measurement
1. Name of intervention
The INtervention FOcused on Quality of Life Measurement (The
INFO-QoL)
2. Goals of intervention
a. Ultimate goal: to prevent/manage impaired quality of life in
advanced cancer patients with palliative care needs in hospice
setting and promote measurement of patient’s quality of life
b. Immediate goals:
i. To reduce prevalence and/or severity of patient’ s problems/
needs
ii. To identify patients at risk of developing impairments in QoL
dimensions
iii. To increase staff awareness of problems/needs, their trajectory,
and appropriate intervention to address them
iv. To inform individual care plans based on impaired QoL
dimensions and local policies
3. Components and activities
a. Component 1: ensure that treatment plans and evaluations focus
on patient rather than disease
i. Goal: to educate staff about QoL issues and about interventions
that promote a better QoL
ii. Activities: discuss the following topics:
– What is QoL in palliative care patients?
– What are the dimensions that contribute to a person’s QoL?
– What are the determinants of changes in self-assessment of
QoL?
– How staff should propose, use, and score QoL tools to patients
– How palliative care staff can effect changes in patients to
improve their QoL
b. Component 2: the Palliative Outcome Scale (POS) as an integral
component of the intervention
i. Goal: patient and family education on using outcome measures
ii. Activities: present the purpose of QoL assessment to patients
and their families; educate patients on using the POS
c. Component 3: QoL measurement using the POS
i. Goal: to promote cohesive, coordinated patient- and family-
centered care
ii. Activities: screening (i.e., baseline) and monitoring individual
patients (morning shift), record individual and overall scores on
individual INFO-QoL form, and discuss results to inform clinical decision
during unit staff briefing
4. Mode of delivery
a. Component 1: small group education session (6–8 palliative care
nurses)
i. Use combination of written and verbal presentation and group
discussion
ii. Written presentation: case-based materials, self-study binders,
poster
iii. Verbal presentation: evidence on QOL issue in palliative care
iv. Group discussion: elicit case discussions to focus on issues
related to patients’ QoL
b. Component 2: nurses-patient and family face-to-face interaction
i. Use combination of written material and verbal communication
ii. Written materials, such as handout on QoL issues, and poster
with large print and simple language hanging in the inpatient
hospice unit
iii. Verbal communication using a slow rate of speech, simple and
common words, short sentences, and a teach-back technique
c. Component 3: individual QoL measurement
i. Nurse team leader is responsible to manage the measurement
(i.e., schedule the measurement, prepare documentation, assign patient
to nurse or nursing assistant, oversee completion of QoL measurement)
ii. Nurse or nursing assistant who perform the QoL measurement
motivates patient to improve compliance
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1. Semi-structured face-to-face interviews to explore
hospice nursing staff members’ experiences and their
role in implementing a nurse-led intervention
focused on QoL measurement
2. Focus groups with nursing staff members to explore
their perspective about a draft version of the INFO-
QoL received a week before the scheduled focus
group sessions
3. A questionnaire survey to assess staff knowledge on
QoL in PC. The questionnaire was developed
according to relevant QoL literature. An academic
working group of experts in PC was set up with the
aim of developing the questionnaire, because a
measure to gather information from PC staff about
their knowledge on QoL issues in PC area did not
exist. Four academic members from the University
of Genoa (Italy) and the Trinity College of Dublin
(UK) discussed and developed the questionnaire.
The Nursing Role Effectiveness Model [18] was used
to guide the development of the questionnaire. The
model is based on the structure-process-outcome
model of quality of care [19]. For item generation,
the structure component comprehends nurses’
knowledge on quality of life in PC, the process
component includes the role of nurses in PC and
specifically QoL assessment-related activities, and
finally, the outcome component was conceptualized
as patient QoL. Sources used for item generation
include a comprehensive review of the published
literature, the quality of life [20], and the Outcome
Measurement in Palliative Care—The Essential [7].
Guided by the conceptual framework, items were
selected and assembled according to Dillman’s
techniques for questionnaire construction [21, 22].
Content validity was systematically assessed and
quantified according to the process described by
Lynn [23]. Twenty-six international experts were
invited to take part in a QoL expert panel, and 14
agreed to participate. Each of them received an email
to explain the objective of the project, a structured
procedure for the evaluation of content validity, and
a link to the online evaluation of the draft version of
the questionnaire consisting of 25 items. Each expert
was invited to rate independently the relevance of
each item using a four-point Likert scale (1: not
relevant; 2: somewhat relevant; 3: quite relevant; 4:
very relevant). The Content Validity Index (CVI)
was computed for each item on a scale (I-CVI), as
well as for the overall scale (S-CVI). For each item,
the I-CVI was computed as number of experts
giving a rating of either 3 or 4, divided by the total
number of experts. The items that had I-CVIs of
0.78 or higher were retained [24]. Of the 25 items,
eight were deleted and three were revised and
included in the questionnaire. The final version of
the INFO-QoL questionnaire was made up of 17
items with a S-CVI/Ave of 0.81 computed using the
averaging method [24].
The results of the questionnaire survey will be used to
inform the QoL education bundle as a component of the
intervention (Component 1 of the INFO-QoL—Table 2).
As a result of this phase, the intervention will be
modeled and linked to a new local procedure.
The exploratory trial (assessing feasibility and piloting
method)
As the INFO-QoL is being implemented throughout the
unit and it will be difficult to deliver the intervention
randomly to some patients but not to others, the feasibility
stage will have a quasi-experimental non-equivalent
comparison group before/after design. Although random-
ized controlled trials represent the gold standard, and
quasi-experimental designs have a weakened confidence in
making causal assertions that the results occurred because
of the intervention, quasi-experimental designs can also
provide useful information to establish whether (and to
what extent) an intervention is effective. A non-equivalent
comparison group design is the strongest of the quasi-
experimental designs and can provide good evidence for
nursing practice. Quasi-experimental designs are more
feasible and more commonly conducted for nursing
studies in clinical settings. This design will enable the
researcher to pilot the components and methods and the
feasibility of the INFO-QoL, in order to assess its accept-
ability in practice and determine whether the INFO-QoL
is delivered according to the study protocol. It will also
offer the opportunity to determine potential effectiveness
of the INFO-QoL in improving patient QoL.
To partially address selection bias, the INFO-QoL
described in Table 2 will be introduced randomly into
unit 1 (intervention unit), while patients and staff in unit
2 (comparison unit) will continue with traditional
clinical practice. By gathering pre-test data, we can
compare the equivalence of the two groups on
Table 2 The intervention focused on quality of life
measurement (Continued)
iii. Staff discusses results and gives feedback of results and care
plan to patient
5. Dose
a. Component 1: self-study binders given 2 weeks before the educa
tion bundle program session; one small group education session of 3-h
duration (repeated at different time points to allow all staff to
participate)
b. Component 2: education session of about 10/15-min duration
c. Component 3: measurement within day 3 from admittance, days
8–10, day 15 and then once a week; patient feedback at the same day
of the measurement
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antecedent variables before introducing of the independ-
ent variable [25]. The study will inform methods for the
future phase 3 trial in determining sample size and the
power of the trial, recruitment, follow-up, and suitability
of measures. For the purpose of this study, the type and
quality of care delivered by sites will not be assessed: it
will be assumed to be at least comparable between the
two hospice units.
Randomization
The unit of randomization is the hospice unit. To
prevent performance bias before randomly allocating the
experimental intervention in one of the two units, the
collection of pre-test data will occur within a three-
month period in both units before making any change.
Subsequently, to reduce the selection bias, the INFO-
QoL will be implemented randomly in “unit 1” (inter-
vention unit), while patients and staff in the “unit 2”
(comparison unit) will continue with the standard
clinical practice.
Randomization will be performed independently by
using a computer-generated sequence. The randomization
procedure will be centralized and managed by an inde-
pendent statistician at the coordinating center of the
study. All study investigators, personnel, and participants
will be unaware of the randomization procedure.
Sample size
According to Cocks and Torgerson [26], this pilot trial
needs a sufficient sample size, so that if our observed
difference between the two groups, in the pilot trial, is
zero, then the upper confidence limit will exclude the
estimate that is considered “clinically significant” in the
planned definitive trial. We will consider a small effect
size of 0.3 and choose a confidence of 80% (that will
satisfy the need for reasonable certainty for trial
decision-making but would be small enough to ensure a
study within a reasonable budget and timeframe). A
sample size of 17 patients for unit/period produces a
one-sided 80% confidence interval with a distance from
the difference in means to the one-sided limit that is
equal to 0.200 when the estimated standard deviations
are 1.00 and 1.00. A 30% attrition rate based on rates
identified in a recent systematic review [27] will lead to
the inclusion of 6 additional patients for a total of 23
patients unit/period.
Outcomes
The modeling phase (phase 1 study)
Both qualitative and quantitative data will be collected
from both staff groups through semi-structured face-to-
face interviews and focus groups. A set of questions to
stimulate responses from the staff members will be gen-
erated according to Patton’s [28] recommendations and
included in an interview protocol. The interviews will be
used to explore nursing staff ’s past experience and role
in implementing an intervention focused on QoL meas-
urement, whereas focus groups with nursing staff mem-
bers will enable them to explore their perspective about
a draft version of the INFO-QoL they will receive a week
before the scheduled focus groups sessions. Two re-
searchers with experience in palliative care will lead the
interviews.
In both units, staff members’ knowledge on QoL will
be assessed through a web survey using the INFO-QoL
questionnaire before randomizing the site that will
receive the intervention and after implementing the
intervention.
Demographic information will be collected, including
age, gender, level of education, professional role, years in
their professional role, and years in PC.
The exploratory trial (phase 2 study)
Feasibility of intervention
Feasibility will be measured in terms of time taken to
organize and perform the intervention and to train
professionals on QoL.
Also, fidelity of intervention will be assessed relating
to deviations from the procedures and uncompleted
measurements (with reasons), recorded using structured
staff self-report checklists.
In addition, professionals will be asked to rate their
competence and level of confidence in delivering the
intervention at different points in time.
Feasibility of the study
Study feasibility will be assessed in terms of time taken
to obtain patients’ informed consent and recruitment
and patient dropout rates.
Acceptability of the study
Acceptability will be evaluated in terms of proportion of
eligible patients (who were approached about the study)
accepting to participate in this study.
Acceptability of intervention from patients’ perspec-
tive Once the delivery of the intervention is completed,
acceptability will be examined using a semi-structured
questionnaire designed and developed for this study.
Patients will be asked to appraise the intervention in
terms of appropriateness and usefulness in identifying
their needs using a QoL tool and to suggest ways to
enhance its acceptability and to identify any missing
elements [29].
Acceptability of intervention from staff ’s perspective
Acceptability will be assessed using a semi-structured
interview including five open questions.
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After implementing the intervention—at the end of a
3-month period—staff members’ acceptability will be
explored in terms of relevance, appropriateness, and
usefulness in addressing QoL of palliative care patients.
To enhance the completeness and acceptability of the
intervention, staff members will be asked to suggest
ways to modify any aspects of the intervention and their
professional views use the INFO-QoL as a standard
practice in the unit.
Prior to staff interviews, the intervention (INFO-QoL)
will be provided to staff in the intervention unit, giving a
fundamental overview of QoL as the main focus of
palliative care. Staff in the intervention unit will then be
asked:
1. How would you comment on the relevance of the
intervention in addressing palliative care patients’
QoL?
2. How would you appraise the intervention overall in
terms of its appropriateness in addressing palliative
care patients’ QoL?
3. How would you appraise the intervention overall in
terms of its usefulness in addressing palliative care
patients’ QoL?
4. Would you suggest modifying any components and/
or activities of the intervention?
5. Would you recommend using the INFO-QoL as a
standard practice within the unit?
Potential effectiveness
QoL will be assessed by collecting data before (period I:
3 months) and after (period II: 3 months) the intervention
and comparing QoL scores in the intervention and
comparison unit using the Italian version of the Palliative
Outcome Scale (POS). The QoL assessment will be per-
formed within day 3 (T0) from admittance, on day 8–10
(T1), and then on day 15 (T2). To reduce detection bias, a
trained research assistant—who will be blind to interven-
tion or comparison status of the unit—will administer the
POS to patients in the comparison unit. Staff will receive
full disclosure of the study purpose. This outcome measure
has been originally validated in advanced cancer patients in
the UK. Cronbach’s alpha for internal consistency was 0.65
and kappa for reliability ranged from 0.8 to 0.62. The
POS includes ten items on physical, psychological,
and spiritual dimensions. Responses to each of the
ten questions range on a scale from 0 to 4. A score
of 0 indicates “not a problem at all” and 4 indicates
“overwhelming” for the patient. The completion time
is 7 min [30]. The psychometric properties of the
Italian version of the POS were acceptable, Cron-
bach’s alpha coefficient was 0.65, and intra-class
correlation coefficient was 0.72 [31].
Demographic patient information will be collected,
including age, gender, education level, marital status,
primary cancer site, and length of time since diagnosis.
We assume that if patients are admitted to hospice with
a primary diagnosis of cancer, they will all have advanced
stage cancer.
Patient management
Patient management will be evaluated using an adapted
version of the composite patient management score by
Detmar et al. [32]. All QoL-related management actions
taken by staff for patients will be calculated by summarizing
all the actions taken. Data will be collected from medical
and nursing charts and ad hoc documentation, which will
comprise the terminology included in the QoL tool (i.e., the
POS) to collect actions delivered to patients for each of
impaired QoL dimensions resulting from the POS score.
Data on these actions will be elements of care pathways
including but not limited to medications, interventions, nu-
trition and dietary, vital signs, diagnostic tests, referrals and
consultations, patient and family counseling, and education.
Ethics statement
The INFO-QoL research project was approved by the
IRCCS AOU San Martino—IST Regional Ethics Com-
mittee (Study #335REG2014). All participants—both
healthcare professionals and patients—will be asked to
sign an informed consent form. Preliminarily, they will
receive a one-page study information sheet, which will
be discussed, and then they will be asked if they would
be willing to participate in the study. Patients will also
be informed that refusing to participate do not affect the
care they need and that they could withdraw their
consent at any time. Also, participants will be informed
that their data will be protected from inappropriate
disclosures according to Italian laws and regulations.
Healthcare professionals invited to participate will be
advised that declining does not lead to any penalty or
loss of benefits otherwise entitled.
Discussion
Despite numerous publications on the issue of patient
QoL, there is a paucity of evidence on how best to address
QoL assessment in clinical practice. The findings of our
project could add important evidence-based knowledge
on this topic. Therefore, our results can help build
knowledge about what components to include in model-
ing an intervention focused on QoL assessment, which is
useful for other implementation projects to learn from. A
clinical intervention focused on QoL assessment provides
innovation for oncology and palliative nursing in several
ways: (1) fostering the simultaneous care model; (2) ensur-
ing that the voices (needs) of people with advanced cancer
are heard; (3) helping at screening and monitoring
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patients’ needs to fully personalize care through evidence-
based nursing interventions; (4) supporting the evidence-
based practice movement to ensure quality of service,
effectiveness and accountability, and personalized care; (5)
facilitating identification of what works and what does not
work in delivering clinical nursing interventions aimed
both at measuring and improving patients’ QoL; and (6)
assuring that patients’ wishes and preferences will be
recorded and understood by health professionals deliver-
ing care to them.
Early initiation of palliative care has been proved to
improve QoL significantly in the outpatient setting [33].
Although this study will be focused on hospice inpatient
units, it will potentially also contribute to gain an in-
depth insight into developing and implementing com-
plex interventions focused on QoL assessment in
settings other than hospice units, such as hospital and
community settings [29, 34]. It may contribute to im-
proving patient’s QoL in advanced disease trajectory as
well. A systematic literature review showed that QoL as-
sessment leads to improved delivery of patients’ physical,
psychological, and social needs [2] and that more rigorous
studies are necessary to establish a routine clinical practice
approach for identifying and addressing patients’ unmet
needs. The innovative approach identified and piloted in
our study may help to fulfill this need, as we have rigor-
ously applied the MRC framework to palliative care
patients in clinical practice, in order to address these key
issues identified in the literature.
This study may also contribute towards the develop-
ment of research in palliative care practice, addressing a
relevant topic for patients, families, and healthcare
professionals. The strength of the study is related to the
multiple components of the intervention based on data
currently available. The structured approach of the inter-
vention may provide a method for identifying informed
care plans and improving patients’ outcomes. Healthcare
palliative professionals involved may find the interven-
tion acceptable for delivery in clinical practice after
receiving formal training in all the preliminary phases of
the study. Moreover, as a consequence of the staff ’s
commitment, training/education received, and expect-
ation of improved patient outcomes, they may decide to
maintain use of the INFO-QoL intervention as standard
practice beyond the duration of this study.
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